Rituximab for chronic inflammatory demyelinating polyneuropathy-A potential therapeutic option
Muscle Nerve
.
2020 May;61(5):549-551.
doi: 10.1002/mus.26871.
Epub 2020 Apr 4.
Authors
Joss C Cohen
1
,
Richard A Lewis
1
Affiliation
1
Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California.
PMID:
32232860
DOI:
10.1002/mus.26871
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating*
Rituximab
Substances
Rituximab